BEMFOLA

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
BEMFOLA

ACTIVE PRINCIPLE
FOLLITROPIN ALFA

TYPE OF DEVICE
PRE-FILLED SYRINGE

LATEX
DO NOT

TEMPERING TIME
5 to 10 min

START OF INJECTION
Inserting the needle into the skin

CLICK TO THE START (IN PEN)
DO NOT

CLICK AT THE END (IN PEN)
DO NOT

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE